KRYS - Company ID 0001711279
The table below shows Krystal Biotech, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $501.31M | $392.60M | $353.83M | $308.77M | $373.97M | $345.79M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $127.02M | $129.63M | $111.44M | $103.26M | $97.30M | $103.24M |
| Inventory | $42.65M | $37.63M | $31.04M | $29.94M | $18.58M | $12.18M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.02B |
| $925.65M |
| $841.35M |
| $766.80M |
| $713.16M |
| $682.77M |
| Property, plant & equipment | $153.58M | $148.87M | $150.39M | $151.07M | $156.59M | $158.81M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.40B | $1.24B | $1.14B | $1.07B | $982.32M | $917.66M |
| Accounts payable | $4.09M | $2.10M | $7.12M | $2.67M | $5.58M | $5.42M |
| Total current liabilities | $107.80M | $91.27M | $86.90M | $79.49M | $89.53M | $71.85M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $120.24M | $102.22M | $97.75M | $89.74M | $96.47M | $78.77M |
| Retained earnings | $80.09M | -$27.24M | -$106.60M | -$144.94M | -$226.15M | -$253.33M |
| Total equity | $1.28B | $1.14B | $1.04B | $984.67M | $885.85M | $838.89M |